TTM
23.1%
YoY change
−9.05pp
Trough year (1988)
-69.9%
Peak year (2017)
46.0%
Latest annual
22.0%
FCF Margin history chart for Amgen (AMGN) from 1988 to 2025
Latest: 22.0%
FCF Margin change chart for Amgen (AMGN) from 1988 to 2025
Latest: −9.05pp
FCF Margin history table for Amgen (AMGN) from 1988 to 2025
| 2025 | 22.0% | -9.05pp | ||
| 2024 | 31.1% | +4.99pp | ||
| 2023 | 26.1% | -7.27pp | ||
| 2022 | 33.4% | +1.11pp | ||
| 2021 | 32.3% | -6.64pp | ||
| 2020 | 38.9% | +2.38pp | ||
| 2019 | 36.5% | -7.94pp | ||
| 2018 | 44.5% | -1.55pp | ||
| 2017 | 46.0% | +4.62pp | ||
| 2016 | 41.4% | +2.49pp | ||
| 2015 | 38.9% | +1.27pp | ||
| 2014 | 37.6% | +7.67pp | ||
| 2013 | 30.0% | -0.10pp | ||
| 2012 | 30.1% | +0.86pp | ||
| 2011 | 29.2% | -5.38pp | ||
| 2010 | 34.6% | -5.06pp | ||
| 2009 | 39.7% | +4.22pp | ||
| 2008 | 35.4% | +7.45pp | ||
| 2007 | 28.0% | -1.25pp | ||
| 2006 | 29.2% | -3.30pp | ||
| 2005 | 32.5% | +10.16pp | ||
| 2004 | 22.4% | -4.07pp | ||
| 2003 | 26.4% | -2.35pp | ||
| 2002 | 28.8% | +2.94pp | ||
| 2001 | 25.9% | -8.85pp | ||
| 2000 | 34.7% | +10.64pp | ||
| 1999 | 24.1% | +0.08pp | ||
| 1998 | 24.0% | +2.02pp | ||
| 1997 | 22.0% | -3.32pp | ||
| 1996 | 25.3% | -6.79pp | ||
| 1995 | 32.1% | +7.31pp | ||
| 1994 | 24.8% | +8.29pp | ||
| 1993 | 16.5% | +9.71pp | ||
| 1992 | 6.8% | -8.31pp | ||
| 1991 | 15.1% | +42.06pp | ||
| 1990 | -27.0% | — | ||
| 1988 | -69.9% | — |
- 202522.0%-9.05pp
- 202431.1%+4.99pp
- 202326.1%-7.27pp
- 202233.4%+1.11pp
- 202132.3%-6.64pp
- 202038.9%+2.38pp
- 201936.5%-7.94pp
- 201844.5%-1.55pp
- 201746.0%+4.62pp
- 201641.4%+2.49pp
- 201538.9%+1.27pp
- 201437.6%+7.67pp
- 201330.0%-0.10pp
- 201230.1%+0.86pp
- 201129.2%-5.38pp
- 201034.6%-5.06pp
- 200939.7%+4.22pp
- 200835.4%+7.45pp
- 200728.0%-1.25pp
- 200629.2%-3.30pp
- 200532.5%+10.16pp
- 200422.4%-4.07pp
- 200326.4%-2.35pp
- 200228.8%+2.94pp
- 200125.9%-8.85pp
- 200034.7%+10.64pp
- 199924.1%+0.08pp
- 199824.0%+2.02pp
- 199722.0%-3.32pp
- 199625.3%-6.79pp
- 199532.1%+7.31pp
- 199424.8%+8.29pp
- 199316.5%+9.71pp
- 19926.8%-8.31pp
- 199115.1%+42.06pp
- 1990-27.0%—
- 1988-69.9%—
FCF Margin values are taken from Amgen's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About FCF Margin at Amgen (AMGN)
According to Amgen's latest reported financial statements, the company's latest reported free cash flow margin is 23.1%. Free cash flow margin is free cash flow divided by revenue — the share of each sales dollar that converts into cash after capital expenditures. Because free cash flow cannot be inflated by non-cash accounting, FCF margin is a clean read on how efficiently a business turns revenue into deployable cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Amgen (AMGN) most recent annual free cash flow margin stands at 22.05% (2025) – contracted 9.1 percentage points year-over-year.
Across the available history, free cash flow margin reached its high of 46.01% in 2017 and its low of -69.94% in 1988.
Amgen FCF Margin by Year
Amgen FCF Margin 2025: 22.0%
2025's free cash flow margin for Amgen came in at 22.05%, contracted 9.1 percentage points from 2024.
Amgen FCF Margin 2024: 31.1%
Amgen posted free cash flow margin of 31.10% in 2024, expanded 5.0 percentage points from 2023.
Amgen FCF Margin 2023: 26.1%
In 2023, Amgen reported free cash flow margin of 26.11%, contracted 7.3 percentage points from 2022.
Amgen FCF Margin 2022: 33.4%
Amgen free cash flow margin in 2022 was 33.37%, expanded 1.1 percentage points from 2021.
Amgen FCF Margin 2021: 32.3%
Amgen free cash flow margin in 2021 was 32.26%.
See more financial history for Amgen (AMGN).
Sector peers by FCF Margin
Healthcare peers of Amgen (AMGN), ranked by their latest free cash flow margin
Frequently asked questions
Amgen (AMGN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation